Provided By PR Newswire
Last update: Oct 3, 2025
NEW YORK, Oct. 3, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Altimmune, Inc. ("Altimmune" or the "Company") (NASDAQ: ALT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Read more at prnewswire.comNASDAQ:ALT (10/14/2025, 11:39:09 AM)
3.8601
-0.14 (-3.5%)
Find more stocks in the Stock Screener